GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 18, 2024
Displaying entries 14751 - 14800 of 40384 in total
PDB ID ▼ UniProt ID Title Descriptor
7E9N 7E9N Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1)
7E9L Q5NDF2 Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man short peptide)
7E9L 7E9L Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man short peptide)
7E9K Q5NDF2 Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man long peptide)
7E9K 7E9K Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man long peptide)
7E9J Q5NDF2 Crystal Structure of POMGNT2 in complex with UDP
7E8M P0DTC2 Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD
7E8M 7E8M Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD
7E7Q P78363 Cryo-EM structure of human ABCA4 in ATP-bound state
7E7O P78363 Cryo-EM structure of human ABCA4 in NRPE-bound state
7E7M A0A6H3FYP2 Crystal Structure Analysis of the Streptococcus agalactiae Ribose Binding Protein RbsB
7E7I P78363 Cryo-EM structure of human ABCA4 in the apo state
7E7D P02452 Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
7E7D P0DTC2 Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
7E7B P02452 Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
7E7B P0DTC2 Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
7E78 Q1PBI3 the structure of cytosolic TaPGI with substrate
7E71 Q8RUT8 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 ms structure
7E71 Q93WP2 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 ms structure
7E70 Q8RUT8 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 250 microsecond structure
7E70 Q93WP2 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 250 microsecond structure
7E6Z Q8RUT8 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 50 microsecond structure
7E6Z Q93WP2 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 50 microsecond structure
7E6Y Q8RUT8 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 microsecond structure
7E6Y Q93WP2 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 microsecond structure
7E6X Q8RUT8 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 4 ms structure
7E6X Q93WP2 Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 4 ms structure
7E6T P41180 Structural insights into the activation of human calcium-sensing receptor
7E6Q A1ILL9 Crystal structure of influenza A virus neuraminidase N5 complexed with 4'-phenyl-1,2,3-triazolylated oseltamivir carboxylate
7E6I P48828 Glucose-6-phosphate dehydrogenase in complex with its substrate glucose-6-phosphate
7E5S P0DTC2 SARS-CoV-2 S trimer with four-antibody cocktail complex
7E5S 7E5S SARS-CoV-2 S trimer with four-antibody cocktail complex
7E5R P0DTC2 SARS-CoV-2 S trimer with three-antibody cocktail complex
7E5R 7E5R SARS-CoV-2 S trimer with three-antibody cocktail complex
7E5O P0DTC2 Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193
7E5O 7E5O Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193
7E5M P09758 crystal structure of trans assembled human TROP-2
7E57 Q7TS55 Crystal structure of murine GITR-GITRL complex
7E57 O35714 Crystal structure of murine GITR-GITRL complex
7E3L P0DTC2 Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
7E3L 7E3L Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
7E3K P0DTC2 Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
7E3K 7E3K Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
7E3J 7E3J Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
7E3J P0DTC2 Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
7E3H P22303 Crystal structure of human acetylcholinesterase in complex with donepezil
7E3G D6XHE1 Crystal structure of Trypanosoma brucei cathepsin B R91C/T223C mutant in the living cell
7E3F D6XHE1 Crystal structure of Trypanosoma brucei cathepsin B Y217C/S275C mutant
7E3E D6XHE1 Crystal structure of Trypanosoma brucei cathepsin B R91C/T223C mutant
7E3D P22303 Crystal structure of human acetylcholinesterase

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024